iMSpc Biotech Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

iMSpc Biotech General Information

Description

Developer of medical technology used for the diagnosis and treatment of hyperuricemia and gout. The company has launched a test product for "risk assessment of acute gout attacks" to diagnose suspected gout patients or predict gout attacks in patients with long-term hyperuricemia, enabling users to accurately and timely diagnose related symptoms and to applied personalized medication.

Contact Information

Website
www.imspc.life
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit A3-201, Bio-Industry Park
  • No. 218 Xinghu Street
  • Suzhou, Jiangsu
  • China
Primary Industry
Medical Supplies
Other Industries
Diagnostic Equipment
Biotechnology
Corporate Office
  • Unit A3-201, Bio-Industry Park
  • No. 218 Xinghu Street
  • Suzhou, Jiangsu
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iMSpc Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 28-May-2024 Completed Generating Revenue
To view iMSpc Biotech’s complete valuation and funding history, request access »

iMSpc Biotech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Suzhou Industrial Park Yisheng Private Equity Fund Management Growth/Expansion Minority
YSCapital Venture Capital Minority
To view iMSpc Biotech’s complete investors history, request access »

iMSpc Biotech FAQs

  • When was iMSpc Biotech founded?

    iMSpc Biotech was founded in 2023.

  • Where is iMSpc Biotech headquartered?

    iMSpc Biotech is headquartered in Suzhou, China.

  • What industry is iMSpc Biotech in?

    iMSpc Biotech’s primary industry is Medical Supplies.

  • Is iMSpc Biotech a private or public company?

    iMSpc Biotech is a Private company.

  • What is iMSpc Biotech’s current revenue?

    The current revenue for iMSpc Biotech is .

  • Who are iMSpc Biotech’s investors?

    Suzhou Industrial Park Yisheng Private Equity Fund Management and YSCapital have invested in iMSpc Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process